$41.20
$-0.53 (-1.27%)
End-of-day quote: 03/11/2024
NasdaqGS:HALO

Halozyme Therapeutics Stock Price

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
14.9
Market Cap
4.77B
Price-to-book Ratio
62.42
Earnings
05/09/2024
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
1.24
Short Interest
5.78%
Forecast 1Y
52.55%
Analyst Price Target
$47.50
LTG 5Y
44.40%
52 week range
$29.85 - $45.00